NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?

Insider buying vs selling

Have Ionis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph LoscalzoDirector2024-11-1213,508$37.86
$511.43kSell
Brett P. MoniaChief Executive Officer2024-11-126,630$38.05
$252.29kSell
Eric SwayzeEVP Research2024-11-121,194$37.92
$45.28kSell
Eric SwayzeEVP Research2024-10-1653$38.31
$2.03kSell
Richard S. GearyEVP Chief Development Officer2024-08-3011$38.64
$425.05Buy
Eric SwayzeEVP Research2024-08-3011$38.64
$425.05Buy
Patrick R. OneilEVP CLO General Counsel2024-08-30246$38.64
$9.51kBuy
Brett P. MoniaChief Executive Officer2024-08-30140$38.64
$5.41kBuy
Brian BirchlerEVP Corp and Development Ops2024-08-3012$38.64
$463.69Buy
C. Frank BennettEVP Chief Scientific Officer2024-08-30177$38.64
$6.84kBuy

1 of 11

IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IONS insiders and whales buy or sell their stock.

IONS Shareholders

What type of owners hold Ionis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.24%22,479,529$856.69MInstitution
Vanguard Group Inc9.54%15,055,758$573.77MInstitution
T Rowe Price Investment Management Inc8.97%14,168,116$539.95MInstitution
Blackrock Inc 16.85%10,813,023$412.08MInstitution
Wellington Management Group LLP5.53%8,735,787$332.92MInstitution
Bellevue Group Ag4.99%7,874,400$300.09MInstitution
Capital World Investors4.96%7,828,372$298.34MInstitution
State Street Corp3.07%4,850,137$184.84MInstitution
Price T Rowe Associates Inc2.67%4,210,172$160.45MInstitution
Tweedy Browne Co LLC 12.19%3,454,676$131.66MInstitution

1 of 3

IONS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IONS96.61%3.39%Net SellingNet Selling
CYTK89.94%10.06%Net SellingNet Selling
BPMC81.81%18.19%Net SellingNet Selling
HALO78.40%21.60%Net SellingNet Buying
CORT31.21%68.79%Net BuyingNet Selling

Ionis Pharmaceuticals Stock Ownership FAQ

Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals (NASDAQ: IONS) is owned by 98.81% institutional shareholders, 3.47% Ionis Pharmaceuticals insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual Ionis Pharmaceuticals shareholder, owning 2.50M shares representing 1.58% of the company. Lilly Co Eli's Ionis Pharmaceuticals shares are currently valued at $95.28M.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.